Medtronic vs STADA

XRlabs Raises €7.48M for AI Surgical Intelligence

London-based XRlabs, a Surgical Intelligence company founded by neurosurgeon Dr. Ali Haddad, has raised €7.48 million ($8.4 million) in Seed funding. The round was led by Playground Global (Palo Alto), with participation from London-based HealthTech investor Eka Ventures. The company develops modular, device-agnostic software that uses computer vision and deep learning to transform live surgical video, navigation telemetry, and pre-operative imaging into a real-time, anatomy-aware view. Its platform has been deployed in over 100 surgical cases across three continents. The funding will support engineering and clinical team expansion, regulatory advancement in the UK, EU, and US, and the extension of clinical evidence. XRlabs also announced Omar Ishrak, former CEO of Medtronic, as Chair of its Board. The company has been awarded compute allocation on the UK AI Research Resource (AIRR).

• XRlabs raised €7.48 million ($8.4 million) in Seed funding led by Playground Global with participation from Eka Ventures.
• Omar Ishrak, former CEO of Medtronic, joined as Chair of XRlabs' Board of Directors.
• The company's platform has been deployed in over 100 surgical cases on three continents.

8-K Financial Filing Analysis for Medtronic (2026-09-01)

On September 1, 2026, Medtronic plc filed a Form 8-K under Item 2.02 (Results of Operations and Financial Condition) announcing its financial results for the first quarter of fiscal year 2027. The details of the quarterly performance were furnished via press release in Exhibit 99.1, signed by Executive Vice President and Chief Financial Officer Thierry Piéton.

• Medtronic plc furnished its Q1 FY2027 financial results via Form 8-K on September 1, 2026.
• The earnings announcement is furnished under Item 2.02 with details provided in Exhibit 99.1.
• The filing was formally authorized and signed by Executive Vice President and CFO Thierry Piéton.

Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.

Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares of common stock of MiniMed Group, Inc.

Huth+Wenzel wins Stada's Elotrans Reload account

Frankfurt-based agency Huth+Wenzel has won the creative account for Stada's Elotrans Reload. The first joint campaign is running immediately through mid-October across social media, Connected TV, linear TV (channels like RTL Zwei), digital out-of-home and ambient placements. The account move ends the prior cooperation with Schmittgall Health, which had handled the brand since the product launch in 2023. The campaign centers on a humorous fictional character named "Stefan" and the agency says it used artificial intelligence as a creative tool to develop Out-of-Home motifs. Claudia Rodrigues (Brand Manager at Stada) and Andreas Liehr (Huth+Wenzel managing director) are quoted on the campaign approach.

• Huth+Wenzel won the creative pitch for Elotrans Reload, a brand of Stada.
• The first Huth+Wenzel campaign for Elotrans Reload runs now until mid-October across social media, Connected TV, linear TV (e.g., RTL Zwei), DOOH and ambient formats.
• The account move ends Stada's prior cooperation with Schmittgall Health, which had managed Elotrans Reload since its 2023 product launch.